Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Sonia Dolfi"'
Autor:
Rupal Bhatt, Ana Lako, Benjamin Chen, Daniel Tenney, Sharmila Chamling Rai, Piali Mukherjee, Brendan O’Brien, Sonia Dolfi
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/e4a0511d1e1c4168840dcb2dd7904820
Autor:
Bradley Garman, Can Jiang, Sherif Daouti, Sanah Kumar, Priyanka Mehta, Miye K. Jacques, Laurence Menard, Nataly Manjarrez-Orduno, Sonia Dolfi, Piali Mukherjee, Sharmila Chamling Rai, Ana Lako, Jennifer D. Koenitzer, Justin M. David
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundImmune cell expression profiling from patient samples is critical for the successful development of immuno-oncology agents and is useful to understand mechanism-of-action, to identify exploratory biomarkers predictive of response, and to gu
Externí odkaz:
https://doaj.org/article/324c0c0207fc4feeb6f9cf0d6a14e5a6
Autor:
Aparna Kareddula, Daniel J. Medina, Whitney Petrosky, Sonia Dolfi, Irina Tereshchenko, Kelly Walton, Hana Aviv, Evita Sadimin, Alexandra L. Tabakin, Eric A. Singer, Kim M. Hirshfield
Publikováno v:
Therapeutic Advances in Urology, Vol 13 (2021)
Background: Prostate cancer (PCa) phenotypes vary from indolent to aggressive. Molecular subtyping may be useful in predicting aggressive cancers and directing therapy. One such subtype involving deletions of chromodomain helicase DNA binding protein
Externí odkaz:
https://doaj.org/article/ca950f5f2b464ee8b0c531557af922af
Autor:
James Larkin, Michele Del Vecchio, Mario Mandalá, Helen Gogas, Ana M. Arance Fernandez, Stéphane Dalle, Charles Lance Cowey, Michael Schenker, Jean-Jacques Grob, Vanna Chiarion-Sileni, Ivan Marquez-Rodas, Marcus O. Butler, Anna Maria Di Giacomo, Mark R. Middleton, Jose Lutzky, Luis de la Cruz-Merino, Petr Arenberger, Victoria Atkinson, Andrew G. Hill, Leslie A. Fecher, Michael Millward, Paul D. Nathan, Nikhil I. Khushalani, Paola Queirolo, Corey Ritchings, Maurice Lobo, Margarita Askelson, Hao Tang, Sonia Dolfi, Paolo A. Ascierto, Jeffrey Weber
Publikováno v:
Clinical Cancer Research. :OF1-OF10
Purpose: In the phase III CheckMate 238 study, adjuvant nivolumab significantly improved recurrence-free survival (RFS) and distant metastasis-free survival versus ipilimumab in patients with resected stage IIIB–C or stage IV melanoma, with benefit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::434061b974def7d4b67a0e16b85e1b6e
https://doi.org/10.1158/1078-0432.ccr-22-3145
https://doi.org/10.1158/1078-0432.ccr-22-3145
Autor:
Paolo Antonio Ascierto, Evan J. Lipson, Reinhard Dummer, James Larkin, Georgina V. Long, Rachel E. Sanborn, Vanna Chiarion-Sileni, Brigitte Dréno, Stéphane Dalle, Dirk Schadendorf, Margaret K. Callahan, Marta Nyakas, Victoria Atkinson, Carlos Alberto Gomez-Roca, Naoya Yamazaki, Hussein A. Tawbi, Naomey Sarkis, Deepti Warad, Sonia Dolfi, Priyam Mitra, Satyendra Suryawanshi, Jean-Jacques Grob
Publikováno v:
Journal of Clinical Oncology
Journal of Clinical Oncology, 2023, Online ahead of print. ⟨10.1200/JCO.22.02072⟩
Journal of Clinical Oncology, 2023, Online ahead of print. ⟨10.1200/JCO.22.02072⟩
PURPOSE Nivolumab and relatlimab activity in advanced melanoma with prior progression on anti–programmed death-1/programmed death ligand 1 (PD-(L)1)-containing regimens is under investigation. RELATIVITY-047 demonstrated significantly improved prog
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d4b28765b673f8d282e8b6a6a86470d
https://www.zora.uzh.ch/id/eprint/234148/
https://www.zora.uzh.ch/id/eprint/234148/
Autor:
Jeffrey Weber, Paolo A. Ascierto, Sonia Dolfi, Hao Tang, Margarita Askelson, Maurice Lobo, Corey Ritchings, Paola Queirolo, Nikhil I. Khushalani, Paul D. Nathan, Michael Millward, Leslie A. Fecher, Andrew G. Hill, Victoria Atkinson, Petr Arenberger, Luis de la Cruz-Merino, Jose Lutzky, Mark R. Middleton, Anna Maria Di Giacomo, Marcus O. Butler, Ivan Marquez-Rodas, Vanna Chiarion-Sileni, Jean-Jacques Grob, Michael Schenker, Charles Lance Cowey, Stéphane Dalle, Ana M. Arance Fernandez, Helen Gogas, Mario Mandalá, Michele Del Vecchio, James Larkin
DATA SUPPLEMENT Adjuvant Nivolumab Versus Ipilimumab in Resected Stage III/IV Melanoma: 5-Year Efficacy and Biomarker Results From CheckMate 238
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52cb1057ddae601989ec0e00460b71a9
https://doi.org/10.1158/1078-0432.22787545.v1
https://doi.org/10.1158/1078-0432.22787545.v1
Autor:
Jeffrey Weber, Paolo A. Ascierto, Sonia Dolfi, Hao Tang, Margarita Askelson, Maurice Lobo, Corey Ritchings, Paola Queirolo, Nikhil I. Khushalani, Paul D. Nathan, Michael Millward, Leslie A. Fecher, Andrew G. Hill, Victoria Atkinson, Petr Arenberger, Luis de la Cruz-Merino, Jose Lutzky, Mark R. Middleton, Anna Maria Di Giacomo, Marcus O. Butler, Ivan Marquez-Rodas, Vanna Chiarion-Sileni, Jean-Jacques Grob, Michael Schenker, Charles Lance Cowey, Stéphane Dalle, Ana M. Arance Fernandez, Helen Gogas, Mario Mandalá, Michele Del Vecchio, James Larkin
Purpose:In the phase III CheckMate 238 study, adjuvant nivolumab significantly improved recurrence-free survival (RFS) and distant metastasis-free survival versus ipilimumab in patients with resected stage IIIB–C or stage IV melanoma, with benefit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30007277e80b61bdf1c2ca6cbcc13787
https://doi.org/10.1158/1078-0432.c.6637744.v1
https://doi.org/10.1158/1078-0432.c.6637744.v1
Autor:
Georgina V. Long, F. Stephen Hodi, Evan J. Lipson, Dirk Schadendorf, Paolo A. Ascierto, Luis Matamala, Pamela Salman, Erika Castillo Gutiérrez, Piotr Rutkowski, Helen J. Gogas, Christopher D. Lao, Juliana Janoski De Menezes, Stéphane Dalle, Ana Arance, Jean-Jacques Grob, Sarah Keidel, Anadil Shaikh, Anne Marie Sobiesk, Sonia Dolfi, Hussein A. Tawbi
Publikováno v:
NEJM Evidence. 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e648ee5c9667edd89181164cc2f6e4c6
https://doi.org/10.1056/evidoa2200239
https://doi.org/10.1056/evidoa2200239
Autor:
Sonia Dolfi, Tracy Tang, Georgina Long AO, Paolo Ascierto, F Stephen Hodi, Evan Lipson, Dirk Schadendorf, John Wojcik, Jennifer Postelnek, Yu Wang, Anne Marie Sobiesk, Kaushal Mishra, Sarah Keidel, Karen Miller-Moslin, Hussein Tawbi, Charlie Garnett-Benson
Publikováno v:
Regular and Young Investigator Award Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e071b53d84af30fd8a79d3dca441b00b
https://doi.org/10.1136/jitc-2022-sitc2022.0606
https://doi.org/10.1136/jitc-2022-sitc2022.0606
Autor:
Hussein A. Tawbi, F. Stephen Hodi, Evan J. Lipson, Dirk Schadendorf, Paolo Antonio Ascierto, Luis Matamala, Pamela Salman, Erika Castillo Gutiérrez, Piotr Rutkowski, Helen Gogas, Christopher D. Lao, Juliana Janoski De Menezes, Stéphane Dalle, Ana Maria Arance, Jean-Jacques Grob, Sarah Keidel, Karin Jonczak, Anne Marie Sobiesk, Sonia Dolfi, Georgina V. Long
Publikováno v:
Journal of Clinical Oncology. 40:9505-9505
9505 Background: In the phase 2/3 RELATIVITY-047 trial, NIVO + RELA as a fixed-dose combination (FDC) significantly improved the primary endpoint of progression-free survival (PFS) versus NIVO in patients (pts) with previously untreated metastatic or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::38cb6033f3dea8bd607d53f110040fbd
https://doi.org/10.1200/jco.2022.40.16_suppl.9505
https://doi.org/10.1200/jco.2022.40.16_suppl.9505